SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640455-20-000051
Filing Date
2020-05-06
Accepted
2020-05-06 13:56:34
Documents
59
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jnce0331202010-q.htm 10-Q 1054134
2 EXHIBIT 31.1 jnce03312020exhibit311.htm EX-31.1 10708
3 EXHIBIT 31.2 jnce03312020exhibit312.htm EX-31.2 10716
4 EXHIBIT 32.1 jnce03312020exhibit321.htm EX-32.1 11732
  Complete submission text file 0001640455-20-000051.txt   4600735

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT jnce-20200331.xml EX-101.INS 853197
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnce-20200331.xsd EX-101.SCH 31325
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jnce-20200331_cal.xml EX-101.CAL 54071
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnce-20200331_def.xml EX-101.DEF 171858
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnce-20200331_lab.xml EX-101.LAB 481807
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnce-20200331_pre.xml EX-101.PRE 287280
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37998 | Film No.: 20852143
SIC: 2836 Biological Products, (No Diagnostic Substances)